Mind Medicine (MindMed) Inc. (MNMD)

NMS – Real vaqt narxi. Valyuta: USD

15.02

+0.15 (1.01%)

Yopilishda: Jan 14, 2026, 4:00 PM EDT

15.01.2026

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

29.12.2025

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MNMD has surged 101% in six months with MM120 advancing in phase III for GAD and MDD. Pivotal readouts are slated for 2026.

18.12.2025

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that Rob Barrow, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT. “It is a privilege to participate in the J.P. Morgan Healthcare Conference as we continue to.

16.12.2025

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

After a weak first half, the drug and biotech sector has recovered in the past 2-3 months with large drugmakers like Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk signing drug pricing agreements with the Trump administration. A rebound in mergers and acquisitions (M&A) has also increased investor confidence in the industry.

15.12.2025

MindMed Announces New Employee Inducement Grant

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common shares of the Company (the "Options") with an effective grant date of December 15, 2025. The Options have an exercise price.

01.12.2025

MindMed Announces New Employee Inducement Grants

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 182,100 common shares of the Company (the “Options”) with effective grant dates of November 17, 2025, November 24, 2025 and December 1, 2.

07.11.2025

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Mind Medicine (MindMed) Inc. ( MNMD ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Robert Barrow - CEO & Director Daniel Karlin - Chief Medical Officer Brandi Roberts - Chief Financial Officer Conference Call Participants Yesha Patel - Evercore ISI Institutional Equities, Research Division Sarah Medeiros - Cantor Fitzgerald & Co., Research Division Matthew Hershenhorn - Oppenheimer & Co. Inc., Research Division François Brisebois - LifeSci Capital, LLC Ami Fadia - Needham & Company, LLC, Research Division Sumant Kulkarni - Canaccord Genuity Corp., Research Division Patrick Trucchio - H.C. Wainwright & Co, LLC, Research Division Christopher Chen - Robert W.

Videolar

No Data

There is no data to display

Press-relizlar

15.12.2025

MindMed Announces New Employee Inducement Grant

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common shares of the Company (the "Options") with an effective grant date of December 15, 2025. The Options have an exercise price.

01.12.2025

MindMed Announces New Employee Inducement Grants

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 182,100 common shares of the Company (the “Options”) with effective grant dates of November 17, 2025, November 24, 2025 and December 1, 2.

06.11.2025

MindMed Reports Q3 2025 Financial Results and Business Updates

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported financial results for the third quarter ended September 30, 2025 and provided business updates. “2025 continues to be a year of strong execution, and our recent $258.9 million financing further strengthens our position as we prepare for a transformational 2026,” sa.

03.11.2025

MindMed Announces New Employee Inducement Grant

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 90,750 common shares of the Company (the "Options") with an effective grant date of November 3, 2025. The Options have an exercise price.

Mind Medicine (MindMed) Inc. (MNMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Mind Medicine (MindMed) Inc. (MNMD)

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

MindMed Reports Q3 2025 Financial Results and Business Updates

MindMed Announces New Employee Inducement Grant

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

MindMed Reports Q3 2025 Financial Results and Business Updates

MindMed Announces New Employee Inducement Grant

Search stocks

Mind Medicine (MindMed) Inc. (MNMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Mind Medicine (MindMed) Inc. (MNMD)

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

MindMed Reports Q3 2025 Financial Results and Business Updates

MindMed Announces New Employee Inducement Grant

Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

MindMed Announces New Employee Inducement Grant

MindMed Announces New Employee Inducement Grants

MindMed Reports Q3 2025 Financial Results and Business Updates

MindMed Announces New Employee Inducement Grant